Karyopharm Therapeutics wins support from holders of all 1L term loan, 1.5L 2028 notes and 2L 2029 notes claims for proposed prepackaged Chapter 11 plan

Observed price moves

• KPTI+4.83%10 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.